HK1108369A1 - Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof - Google Patents

Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof

Info

Publication number
HK1108369A1
HK1108369A1 HK07113628.6A HK07113628A HK1108369A1 HK 1108369 A1 HK1108369 A1 HK 1108369A1 HK 07113628 A HK07113628 A HK 07113628A HK 1108369 A1 HK1108369 A1 HK 1108369A1
Authority
HK
Hong Kong
Prior art keywords
reverse micelles
acylglycerols
phytosterols
therapeutic use
micelles based
Prior art date
Application number
HK07113628.6A
Other languages
English (en)
Inventor
Jean-Claude Maurel
Original Assignee
Medesis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma Sa filed Critical Medesis Pharma Sa
Publication of HK1108369A1 publication Critical patent/HK1108369A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07113628.6A 2004-11-02 2007-12-13 Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof HK1108369A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04025991A EP1652513A1 (fr) 2004-11-02 2004-11-02 Micelles inversées basés sur des stérols et des acylglycerols and leur utilisation thérapeutique
PCT/IB2005/003592 WO2006048772A2 (fr) 2004-11-02 2005-11-02 Micelles inverses a base de phytosterols et d'acylgycerols et leurs utilisations therapeutiques

Publications (1)

Publication Number Publication Date
HK1108369A1 true HK1108369A1 (en) 2008-05-09

Family

ID=34927201

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113628.6A HK1108369A1 (en) 2004-11-02 2007-12-13 Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof

Country Status (17)

Country Link
US (1) US8637314B2 (fr)
EP (2) EP1652513A1 (fr)
JP (1) JP4954079B2 (fr)
CN (1) CN101102747B (fr)
AT (1) ATE503458T1 (fr)
AU (1) AU2005300252B2 (fr)
CA (1) CA2584980C (fr)
DE (1) DE602005027231D1 (fr)
DK (1) DK1807046T3 (fr)
EA (1) EA012453B1 (fr)
ES (1) ES2360809T3 (fr)
HK (1) HK1108369A1 (fr)
IL (1) IL182747A (fr)
PL (1) PL1807046T3 (fr)
PT (1) PT1807046E (fr)
WO (1) WO2006048772A2 (fr)
ZA (1) ZA200704285B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652512A1 (fr) * 2004-11-02 2006-05-03 Medesis Pharma Composition à base de micelles inverses pour l'administration de cations métalliques comprenant un diglycéride et un phytostérol, et procédé de préparation
WO2011117333A2 (fr) * 2010-03-24 2011-09-29 Medesis Pharma Système de micelle inverse comprenant des ions métalliques et son utilisation
JP6038017B2 (ja) * 2010-03-24 2016-12-07 メデシス・ファルマ・ソシエテ・アノニムＭｅｄｅｓｉｓ Ｐｈａｒｍａ Ｓ．Ａ． 核酸を含む逆ミセル系及びその使用
CN102940654A (zh) * 2012-10-12 2013-02-27 江苏大学 一种金针菇不皂化提取物甾醇的三元纳米胶束及其制备方法
CN103203192B (zh) * 2013-02-05 2015-08-12 东华大学 一种非离子反胶束体系及其改性极性物质的方法
CN116459214A (zh) 2015-07-09 2023-07-21 麦迪西斯医药公司 在生物相容性反胶束系统内原位制备氰基桥接的金属纳米粒子的方法
WO2017031392A1 (fr) * 2015-08-20 2017-02-23 University Of Florida Research Foundation, Incorporated Composés lipidiques pour le traitement de l'obésité, de l'hypertension et du syndrome métabolique
CN108822228A (zh) * 2018-06-28 2018-11-16 广东省农业科学院蚕业与农产品加工研究所 一种荔枝多糖的快速纯化方法
WO2023025899A2 (fr) * 2021-08-26 2023-03-02 Transgene Système de distribution pour cibler des gènes de la voie de l'interféron

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
DE4038385C2 (de) * 1990-12-01 1998-09-17 Hoyer Gmbh & Co Kg Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit
FR2729957B1 (fr) * 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
DE19539429C1 (de) * 1995-10-24 1997-04-24 Kawes S L Wasser/Öl-Misch-Emulgator sowie dessen Verwendung in kosmetischen und pharmazeutischen Salben, Cremes, Lotionen, Seifen, Shampoos und Badezusätzen
US5693516A (en) * 1995-11-27 1997-12-02 Novo Nordisk Biotech, Inc. Method for solubilizing proteins in organic solvents
FR2750606B1 (fr) * 1996-07-03 1999-01-29 Maurel Sante Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant
WO2001015201A2 (fr) * 1999-08-26 2001-03-01 University Of New Hampshire Spectrometre de masse a plusieurs etapes
US6951655B2 (en) * 2001-10-11 2005-10-04 Imi Biomed, Inc. Pro-micelle pharmaceutical compositions
JP5100974B2 (ja) * 2004-04-28 2012-12-19 花王株式会社 油脂組成物
EP1652512A1 (fr) * 2004-11-02 2006-05-03 Medesis Pharma Composition à base de micelles inverses pour l'administration de cations métalliques comprenant un diglycéride et un phytostérol, et procédé de préparation

Also Published As

Publication number Publication date
EA012453B1 (ru) 2009-10-30
CN101102747A (zh) 2008-01-09
DK1807046T3 (da) 2011-05-23
EP1807046A2 (fr) 2007-07-18
IL182747A (en) 2011-12-29
EA200700993A1 (ru) 2007-10-26
DE602005027231D1 (de) 2011-05-12
IL182747A0 (en) 2007-07-24
JP2008519025A (ja) 2008-06-05
JP4954079B2 (ja) 2012-06-13
EP1652513A1 (fr) 2006-05-03
CA2584980A1 (fr) 2006-05-11
CA2584980C (fr) 2014-01-07
PL1807046T3 (pl) 2011-09-30
WO2006048772A2 (fr) 2006-05-11
EP1807046B1 (fr) 2011-03-30
AU2005300252B2 (en) 2010-08-26
US20090087406A1 (en) 2009-04-02
WO2006048772A3 (fr) 2006-10-19
PT1807046E (pt) 2011-05-06
ES2360809T3 (es) 2011-06-09
CN101102747B (zh) 2012-10-24
AU2005300252A1 (en) 2006-05-11
US8637314B2 (en) 2014-01-28
ATE503458T1 (de) 2011-04-15
ZA200704285B (en) 2009-04-29

Similar Documents

Publication Publication Date Title
HK1108369A1 (en) Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof
WO2008021088A3 (fr) Les salicylanilides renforcent l'administration par voie orale de peptides thérapeutiques
EP4327888A3 (fr) Formulations orales d'analogues de cytidine et leurs procédés d'utilisation
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
EP2322146A3 (fr) Formules multi-particules comprenant deux principes actives
WO2006004449A3 (fr) Composition combinee
MXPA05002814A (es) Formulacion para agentes lipofilicos.
IL178822A (en) Amide @@ - @Phenylamino-Quinzoline-6-YL, medicinal preparations containing them, and their use in the preparation of drugs for the treatment of proliferative disorders
WO2005112633A3 (fr) Composes et compositions pour administration d’agents actifs
WO2003092580A3 (fr) Methodes et compositions pour le traitement des troubles du systeme nerveux central et du systeme nerveux peripherique et nouveaux composes associes
IL151503A0 (en) Therapeutic combinations of antihypertensive and antiagiogenic agents
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
WO2007025005A3 (fr) Formulations de nalbuphine a liberation prolongee
NO20062198L (no) Bradykinin B1 reseptorantagonister
SG159559A1 (en) Pharmaceutical product
WO2007035783A3 (fr) Preparations combinees d'analogues de cytidine et d'agents platine
WO2004066983A3 (fr) Liberation controlee d'agents hautement solubles
WO2005044187A3 (fr) Preparations pharmaceutiques inhalables employant de l'anhydrate de lactose, et methodes d'administration desdites preparations
WO2006064228A3 (fr) Composes
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
AU2003231260A1 (en) Catechin multimers as therapeutic drug delivery agents
WO2006117404A3 (fr) Utilisation de piegeurs de radicaux dans une preparation topique pour un traitement antipyretique
WO2005056520A8 (fr) Composes actifs du sous-type 1 de recepteur de somatostatine (sstr1) et leur utilisation en therapie
EP1273301A3 (fr) Préparations pharmaceutiques comprenant des principes actifs susceptibles d'administration illicite
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181102